Validation of venous thromboembolism diagnoses in patients receiving rivaroxaban or warfarin in The Health Improvement Network.

Ana Ruigómez Gunnar Brobert Pareen Vora Luis Alberto García-Rodríguez

Published in: Pharmacoepidemiology and drug safety (2020)

Among rivaroxaban/warfarin users in THIN, valid VTE case identification requires manual review of patient records including the free text to prevent outcome misclassification and substantial overestimation of VTE incidence rates.

Keyphrases

venous thromboembolism
direct oral anticoagulants
public health
healthcare
case report
risk factors
mental health
health information
smoking cessation
atrial fibrillation
social media
oral anticoagulants